Richard Barry insider trades: Filana Therapeutics (FLNA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | FLNA | ↑ Buy | 306,813 | $0.91 | $278K | By Trust | Oct 1, 2026 (1d) |
| Sep 28, 2026 | FLNA | ↑ Buy | 93,091 | $0.84 | $78K | By Trust | Sep 30, 2026 (2d) |
| Nov 20, 2025 | SAVA | ↑ Buy | 150,000 | $2.76 | $414K | By Trust | Nov 24, 2025 (4d) |
| Nov 19, 2025 | SAVA | ↑ Buy | 73,385 | $2.75 | $202K | By Trust | Nov 20, 2025 (1d) |
| Sep 22, 2025 | SAVA | ↑ Buy | 7,172 | $2.28 | $16K | By Trust | Sep 23, 2025 (1d) |
| Sep 19, 2025 | SAVA | ↑ Buy | 237,941 | $2.25 | $535K | By Trust | Sep 22, 2025 (3d) |
| Nov 3, 2023 | SRPT | ↑ Buy | 40,000 | $78.81 | $3.2M | By Trust | Nov 6, 2023 (3d) |
| Nov 3, 2023 | SRPT | ↑ Buy | 10,000 | $78.81 | $788K | By LLC | Nov 6, 2023 (3d) |
| Aug 22, 2023 | SAVA | ↑ Buy | 18,477 | $16.67 | $308K | By Trust | Aug 23, 2023 (1d) |
| Mar 7, 2023 | SAVA | ↑ Buy | 88,841 | $25.81 | $2.3M | By Trust | Mar 8, 2023 (1d) |
| Aug 23, 2022 | SAVA | ↑ Buy | 36,159 | $23.79 | $860K | By Trust | Aug 25, 2022 (2d) |
| Aug 7, 2020 | SRPT | ↓ Sell | 30,000 | $158.50 | $4.8M | Direct | Aug 7, 2020 (0d) |
| May 15, 2020 | SRPT | ↓ Sell | 30,000 | $141.26 | $4.2M | Direct | May 15, 2020 (0d) |
| Sep 13, 2019 | SRPT | ↑ Buy | 5,000 | $87.49 | $437K | Direct | Sep 16, 2019 (3d) |
| Aug 20, 2019 | SRPT | ↑ Buy | 5,000 | $99.32 | $497K | Direct | Aug 20, 2019 (0d) |
| Aug 14, 2019 | SRPT | ↑ Buy | 3,700 | $122.50 | $453K | Direct | Aug 14, 2019 (0d) |
| Aug 12, 2019 | SRPT | ↑ Buy | 1,300 | $122.50 | $159K | Direct | Aug 13, 2019 (1d) |
| Jun 27, 2018 | SRPT | ↓ Sell10b5-1 | 75,000 | $130.34 | $9.8M | Direct | Jun 29, 2018 (2d) |
| Mar 14, 2016 | SRPT | ↑ Buy | 75,000 | $15.66 | $1.2M | Direct | Mar 16, 2016 (2d) |
| Dec 17, 2012 | TELK | ↓ Sell | 48,390 | $1.86 | $90K | Direct | Dec 19, 2012 (2d) |
| Dec 13, 2012 | TELK | ↓ Sell | 102,718 | $2.05 | $210K | Direct | Dec 14, 2012 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Richard Barry's insider trades
Richard Barry is President & CEO at Filana Therapeutics (FLNA). Since Dec 13, 2012, Richard has reported 16 open-market purchases worth $11.6M and 5 sales worth $19.1M on SEC Form 4. In the last 12 months: 4 buys ($972K).
1 sale (51% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (17 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FLNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.